German multinational pharmaceutical company Bayer has announced plans to voluntarily withdraw its new drug application in the US for Aliqopa (copanlisib) to treat relapsed follicular lymphoma (FL) following a failed trial.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,